Understanding how RIF1 and KAP1 enable the choice of the future active and inactive X chromosomes: the establishment of functional asymmetry.

点击翻译按钮获取中文摘要

In humans, every chromosome is present in two copies, except in men, where there is one copy of each of the sex chromosomes, the X and the Y. Women have two copies of the X chromosome. One of the two X chromosomes in women is inactivated (silenced), so that male and female cells have the same amounts of the gene products coming from the X chromosomes. This process of silencing is called X-inactivation. Either of the two X chromosomes can be inactivated randomly. This means that, in every tissue, half of the cells would have one X chromosome inactive (A) and half would have the other one inactive (B). How is the random choice of one of the two X chromosome initially made? What are the mechanisms that inform one chromosome that other has been chosen? How is a different choice stably maintained in the progeny of each cell, throughout the life of an individual? These are all still unanswered or only partially-answered questions. In addition, in reality, the two copies of the X chromosome are never completely identical and the small differences in their DNA sequences can result in one of the two copies being silenced more easily. As a consequence, for example, if it is easier to silence X chromosome A, then most of the cells in a human organ will have an active B X chromosome, rather than a mixture of cells with an active A and cells with an active B. This is very important when one of the two X chromosomes contains a completely or partially defective gene which can cause a disease. If the X chromosome that is preferentially silenced carries the disease version of the gene, the organ will be functional and the woman will be healthy. But if, instead, the X chromosome, which is preferentially silenced, is the one carrying the normal version of the gene, the organ will not be able to function properly and the woman will suffer from the disease. Identifying the features of the DNA sequences that drive this skew and understanding how X-inactivation works are therefore very important, as they will allow the early identification of the patients at risk of developing severe symptoms, among the women carriers of X-linked diseases. An example of such a disease, where skewed X-inactivation plays a role in the severity of the symptoms, is Duchenne muscular dystrophy, where some female patients are completely asymptomatic and others are severely ill.In our project, we use mouse embryonic stem cells to investigate three molecules, an RNA and two proteins, that we have shown to be essential for the initial choice of which X chromosome will be inactivated. By studying how these three molecules interact with each other and with the X chromosome DNA, we will identify the molecular mechanism that establishes the choice of the identity of the future active and inactive X chromosomes. In addition, we will explore the role of DNA sequences that can determine skewed X chromosome silencing and investigate how these sequences relate to the unbalanced X chromosome inactivation observed in patients.